Evidence map›Paper›PMID 32706494›Full record

ArticlePediatric blood & cancer2020

Long-term renal function after treatment for unilateral, nonsyndromic Wilms tumor. A report from the St. Jude Lifetime Cohort Study.

Daniel M Green, Mingjuan Wang, Matthew J Krasin, Andrew M Davidoff, DeoKumar Srivastava, Dennis W Jay, Kirsten K Ness, Barry L Shulkin, Sheri L Spunt, Deborah P Jones and 9 more

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Pediatric blood & cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05735977 (An Open Label Cohort Study Assessing the Near Infrared Fluoroscopic Macro and Microscopic Appearances of Paediatric Renal Parenchyma and Tumours Following Ex-vivo Injection of Indocyanine Green), which is not on this map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05735977 nacompletednot on this mapstarted 2023, after this paper: background citation

An Open Label Cohort Study Assessing the Near Infrared Fluoroscopic Macro and Microscopic Appearances of Paediatric Renal Parenchyma and Tumours Following Ex-vivo Injection of Indocyanine Green

TypeinterventionalSponsorBirmingham Women's and Children's NHS Foundation TrustRan2023 to 2025Enrolled12ConditionsWilms Tumor, Renal CancerArmsIndocyanine Green (ICG)
3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Article
  3. Observational
  4. Article
  5. Article
  6. Article
  7. Review
  8. Hypertension in Wilms tumor.Pediatric nephrology (Berlin, Germany) · 2024
    Review
  9. Nephron-sparing surgery for Wilms tumor.Frontiers in pediatrics · 2023
    Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 2 institutions in 1 country.

Daniel M GreenDepartment of Epidemiology and Cancer Control, and Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-5156-5410
Mingjuan WangDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Matthew J KrasinDepartment of Radiation Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Andrew M DavidoffDepartment of Surgery, St. Jude Children's Research Hospital, Memphis, Tennessee.
DeoKumar SrivastavaDepartment of Biostatistics, St. Jude Children's Research Hospital, Memphis, Tennessee.
Dennis W JayDepartment of Pathology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Kirsten K NessDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0002-2084-1507
Barry L ShulkinDepartment of Diagnostic Imaging, St. Jude Children's Research Hospital, Memphis, Tennessee.ORCID 0000-0003-4784-7914
Sheri L SpuntDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Deborah P JonesDepartment of Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee.
Jennifer Q LanctotDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Kyla C SheltonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Rachel C BrennanDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, and Department of Ophthalmology, University of Tennessee College of Medicine, Memphis, Tennessee.ORCID 0000-0002-2090-4395
Daniel A MulrooneyDepartment of Epidemiology and Cancer Control, and Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, and the Department of Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee.
Matthew J EhrhardtDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Todd M GibsonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Beth A KurtDepartment of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee.
Leslie L RobisonDepartment of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, Tennessee.
Melissa M HudsonDepartment of Epidemiology and Cancer Control, and Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, and the Department of Pediatrics, University of Tennessee College of Medicine, Memphis, Tennessee.
St. Jude Children's Research Hospital · USUniversity of Tennessee Health Science Center · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
The St. Jude Lifetime CohortU01CA195547 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI HUDSON, MELISSA M, NESS, KIRSTEN KIMBERLIE · 2015 to 2024
$14.9M
NCI NIH HHS CA195547NCI NIH HHS CA21765NCI NIH HHS P30 CA021765NCI NIH HHS U01 CA195547
6 · The paper itself

Abstract

backgroundThe impact of specific treatment modalities on long-term renal function and blood pressure among adult survivors of Wilms tumor (WT) has not been well documented.

methodsAmong 40 WT survivors and 35 noncancer controls, we estimated the glomerular filtration rate (eGFR) using the Chronic Kidney Disease-Epidemiology (CKD-EPI) equations with and without cystatin C, obtained 24-hour ambulatory blood pressure readings, and, among survivors only, measured

resultsTwenty-six (65%) WT survivors were female, and 33 (83%) were non-Hispanic white. GFR estimated with creatinine or creatinine + cystatin C was decreased among irradiated survivors compared with controls. No irradiated or unirradiated participant had an eGFR (creatinine + cystatin C) < 60 mL/min/1.73 m

conclusionsChronic kidney disease was infrequent in long-term survivors of unilateral nonsyndromic WT, whether treated with WART or no radiation. The prevalence of hypertension was increased in both groups compared with controls, emphasizing the need for ongoing monitoring of renal and cardiovascular health.

Indexed as

AdultBiomarkersBlood Pressure Monitoring, AmbulatoryCase-Control StudiesChild, PreschoolCreatinineFemaleFollow-Up StudiesGlomerular Filtration RateHumansHypertensionKidney Function TestsKidney NeoplasmsMalePilot ProjectsPrevalenceBiomarkersCreatininehypertensionnephrectomyrenal functionwhole abdomen radiation therapyWilms tumor

Identifiers

PMID32706494
PMCPMC7735383
OpenAlexW3044165899

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.